Roivant Sciences Ltd. - Significant Ownership

Signature - Title
/s/ Keyur Parekh - Keyur Parekh, Authorized Signatory
Location
London
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Roivant Sciences Ltd..

Significant Ownership of Roivant Sciences Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IMVT Immunovant, Inc. Common Stock, par value $0.0001 per share 56.9% $1.42B 96.7M 0% Roivant Sciences Ltd. Apr 21, 2025
ABUS Arbutus Biopharma Corp Common Shares, without par value 20.5% $122M 38.8M 0% Roivant Sciences Ltd. Feb 21, 2025

Schedules 13D/G Reported by Roivant Sciences Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.